MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

From Medicineworld.org: Letrozole superior to Tamoxifen in adjuvant setting

Breast cancer treatment Breast cancer main Breast cancer news  

Letrozole superior to Tamoxifen in adjuvant setting


Letrozole may be superior to tamoxifen for post-menopausal women who have breast cancer as per the results of a study presented at the Primary Therapy of Breast Cancer 9th International Conference. The study showed that the risk of recurrence of breast cancer would be reduced 19 percent further if women were treated with letrozole rather than with tamoxifen.

These results were presented by Beat Thurlimann PhD from Kantonsspital-St, Gallen and came out of a large phase III clinical trial involving 8,028 post menopausal women who had endocrine responsive tumors. The median age of patients who participated in the study was 61 years. Forty one percent of these patients had node positive breast cancer. The study compared 2.5 mg daily of letrozole against 20 mg daily of tamoxifen.

The study design comprised of four arms, tamoxifen for five years, letrozole for five years, two years of tamoxifen followed by three years of letrozole and two years of letrozole followed by three years of tamoxifen. Only the data from tamoxifen alone and letrozole alone were available at the time of presentation of the study. At the time of presentation the patients had a median follow up of 35.5 months, however more than 1,200 were followed more than 5 years.

A total of 4,003 patients received letrozole and 4,011 patients received tamoxifen. Letrozole was shown to significantly prolong progression free survival compared with tamoxifen (84% Vs 81.4%). There was no significant difference in overall survival between letrozole arm and tamoxifen arm.

Tamoxifen was associated with 62 percent higher incidence of grade-3 to grade-5 thromboembolic events. There were more vaginal bleeding and endometrial abnormalities in the tamoxifen arm compared to letrozole arm. On the other hand use of letrozole was associated with 44 percent higher incidence of bone fractures.

Cancer terms:
Anemia: Red cells of the blood contain a substance called hemoglobin. Hemoglobin is responsible for transporting oxygen from the lungs to different parts of the body. When the hemoglobin is low the condition is called anemia. Anemia may cause symptoms like fatigue, tiredness and weakness. See cancer terms for more cancer related terms.

Medicineworld.org: Letrozole superior to Tamoxifen in adjuvant setting

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Treatment by stage| Surgical treatment| Chemotherapy| Chemo drugs| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy| Radiation therapy| Monoclonal therapy| High dose chemotherapy| Recurrent breast cancer| Bisphosphonates| Pregnancy and breast cancer| Risk factors| Risk details| My risk| Comprehensive| Breast cancer statistics| African Americans| Ashkenazi| Asians| Hispanic| Men| Native Americans| Older women| Younger women| Pregnant women| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.